China Pharma CPHI Stock
China Pharma Price Chart
China Pharma CPHI Financial and Trading Overview
China Pharma stock price | 0.13 USD |
Previous Close | 0.37 USD |
Open | 0.38 USD |
Bid | 0.38 USD x 3000 |
Ask | 0.4 USD x 1400 |
Day's Range | 0.35 - 0.38 USD |
52 Week Range | 0.27 - 2.6 USD |
Volume | 221.93K USD |
Avg. Volume | 495.02K USD |
Market Cap | 3.6M USD |
Beta (5Y Monthly) | 0.497887 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.27 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
CPHI Valuation Measures
Enterprise Value | 11.04M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.4257439 |
Price/Book (mrq) | 0.6688952 |
Enterprise Value/Revenue | 1.305 |
Enterprise Value/EBITDA | -30.006 |
Trading Information
China Pharma Stock Price History
Beta (5Y Monthly) | 0.497887 |
52-Week Change | -83.18% |
S&P500 52-Week Change | 20.43% |
52 Week High | 2.6 USD |
52 Week Low | 0.27 USD |
50-Day Moving Average | 0.35 USD |
200-Day Moving Average | 0.92 USD |
CPHI Share Statistics
Avg. Volume (3 month) | 495.02K USD |
Avg. Daily Volume (10-Days) | 787.04K USD |
Shares Outstanding | 9.74M |
Float | 5.87M |
Short Ratio | 0.18 |
% Held by Insiders | 51.78% |
% Held by Institutions | 1.06% |
Shares Short | 117.53K |
Short % of Float | 2.00% |
Short % of Shares Outstanding | 1.20% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -40.41% |
Operating Margin (ttm) | -35.86% |
Gross Margin | -1.73% |
EBITDA Margin | -4.34% |
Management Effectiveness
Return on Assets (ttm) | -9.87% |
Return on Equity (ttm) | -68.32% |
Income Statement
Revenue (ttm) | 8.46M USD |
Revenue Per Share (ttm) | 1.39 USD |
Quarterly Revenue Growth (yoy) | 22.19% |
Gross Profit (ttm) | N/A |
EBITDA | -367880 USD |
Net Income Avi to Common (ttm) | -3419327 USD |
Diluted EPS (ttm) | -0.62 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 1.17M USD |
Total Cash Per Share (mrq) | 0.12 USD |
Total Debt (mrq) | 8.65M USD |
Total Debt/Equity (mrq) | 185.28 USD |
Current Ratio (mrq) | 0.51 |
Book Value Per Share (mrq) | 0.553 |
Cash Flow Statement
Operating Cash Flow (ttm) | -998320 USD |
Levered Free Cash Flow (ttm) | 52.76K USD |
Profile of China Pharma
Country | United States |
State | N/A |
City | Haikou |
Address | No. 17, Jinpan Road |
ZIP | 570216 |
Phone | 86 89 8668 11730 |
Website | https://www.chinapharmaholdings.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 234 |
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension. The company also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. It offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. The company provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It offers its products through distributors, its network of sales offices, and sales representatives. The company is based in Haikou, the People's Republic of China.
Q&A For China Pharma Stock
What is a current CPHI stock price?
China Pharma CPHI stock price today per share is 0.13 USD.
How to purchase China Pharma stock?
You can buy CPHI shares on the NYSE American exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for China Pharma?
The stock symbol or ticker of China Pharma is CPHI.
Which industry does the China Pharma company belong to?
The China Pharma industry is Drug Manufacturers-Specialty & Generic.
How many shares does China Pharma have in circulation?
The max supply of China Pharma shares is 19.25M.
What is China Pharma Price to Earnings Ratio (PE Ratio)?
China Pharma PE Ratio is now.
What was China Pharma earnings per share over the trailing 12 months (TTM)?
China Pharma EPS is -0.27 USD over the trailing 12 months.
Which sector does the China Pharma company belong to?
The China Pharma sector is Healthcare.
China Pharma CPHI included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NYSE AMEX COMPOSITE INDEX XAX | 4492.99 USD — |
-2.49
|
— — | 4392.66 USD — | 4625.81 USD — | — - | — — |
- {{ link.label }} {{link}}